AVY
36
2
CMS
65
-2
AZO
48
-2
CCL
55
4
AIZ
69
3
CMA
77
-3
C
58
-4
CB
65
7
BAX
30
-2
DVA
46
-6
AXP
53
-2
AIG
57
-2
CAG
34
-5
AME
56
2
EA
44
-6
CFG
63
-6
CME
52
2
AEE
68
-5
AMZN
53
2
AAL
42
3
AVY
36
2
CMS
65
-2
AZO
48
-2
CCL
55
4
AIZ
69
3
CMA
77
-3
C
58
-4
CB
65
7
BAX
30
-2
DVA
46
-6
AXP
53
-2
AIG
57
-2
CAG
34
-5
AME
56
2
EA
44
-6
CFG
63
-6
CME
52
2
AEE
68
-5
AMZN
53
2
AAL
42
3
Financhill
Back

Rhythm Pharmaceuticals, Inc. 10K Form

Buy
53

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$100.27
Seasonality Move:
19.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RYTM News And Ratings

See the #1 stock for the next 7 days that we like better than RYTM

RYTM Financial Statistics

Sales & Book Value

Annual Sales: $130.1M
Cash Flow: $-23.3M
Price / Cash Flow: 0
Annual Sales: $-0.19
Price / Book: 308.47

Profitability

EPS (TTM): -3.01000
Net Income (TTM): $-183.1M
Gross Margin: $116.1M
Return on Equity: -1153.88%
Return on Assets: -48.22%

Rhythm Pharmaceuticals, Inc. Earnings Forecast

Key Rhythm Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 13 years for RYTM is 89.18%.
  • The Selling, General & Administrative Expenses for RYTM have been equal to 110.90% of Gross Profit Margin.
  • The Research & Development expenses have been 182.32% of Revenue.
  • The Net Earning history of RYTM is -200.27% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 6 years.

Rhythm Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RYTM
CUSIP: 76243J
Website: rhythmtx.com

Debt

Debt-to-Equity Ratio: -21.79
Current Ratio: 2.79
Quick Ratio: 2.45

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RYTM Technical Analysis vs Fundamental Analysis

Buy
53
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy or a Sell?